ArticleDiagnostics (Basel, Switzerland)2023
MSRNet: Multiclass Skin Lesion Recognition Using Additional Residual Block Based Fine-Tuned Deep Models Information Fusion and Best Feature Selection.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- MorphoNet: An Interpretable Hierarchical Deep Learning Framework for Multi-Class Skin Lesion Classification Using Dermoscopic Morphology.Bioengineering (Basel, Switzerland) · 2026Article
- Skin cancer detection using late fusion of pretrained models.Scientific reports · 2026Article
- Federated learning for privacy-preserving skin cancer classification using deep neural networks.Frontiers in oncology · 2026Article
- Multimodal deep learning ensemble framework for skin cancer detection.Scientific reports · 2025Article
- Advancing skin cancer diagnosis with deep learning and attention mechanisms.Scientific reports · 2025Article
- Active Learning with Particle Swarm Optimization for Enhanced Skin Cancer Classification Utilizing Deep CNN Models.Journal of imaging informatics in medicine · 2025Article
- Artificial Intelligence in the Histopathological Assessment of Non-Neoplastic Skin Disorders: A Narrative Review with Future Perspectives.Medical sciences (Basel, Switzerland) · 2025Review
- EAAC-Net: An Efficient Adaptive Attention and Convolution Fusion Network for Skin Lesion Segmentation.Journal of imaging informatics in medicine · 2025Article
- CAD-Skin: A Hybrid Convolutional Neural Network-Autoencoder Framework for Precise Detection and Classification of Skin Lesions and Cancer.Bioengineering (Basel, Switzerland) · 2025Article
- A skin disease classification model based on multi scale combined efficient channel attention module.Scientific reports · 2025Article
- A robust deep learning framework for multiclass skin cancer classification.Scientific reports · 2025Article
- Robustly detecting mpox and non-mpox using a deep learning framework based on image inpainting.Scientific reports · 2025Article
- An Enhanced Approach Using AGS Network for Skin Cancer Classification.Sensors (Basel, Switzerland) · 2025Article
- Investigating the Key Trends in Applying Artificial Intelligence to Health Technologies: A Scoping Review.PloS one · 2025Article
- Article
- Article
- Enhancing Skin Cancer Diagnosis Using Swin Transformer with Hybrid Shifted Window-Based Multi-head Self-attention and SwiGLU-Based MLP.Journal of imaging informatics in medicine · 2024Article
- Boosted dipper throated optimization algorithm-based Xception neural network for skin cancer diagnosis: An optimal approach.Heliyon · 2024Article
- A precise model for skin cancer diagnosis using hybrid U-Net and improved MobileNet-V3 with hyperparameters optimization.Scientific reports · 2024Article
- A Multi-level ensemble approach for skin lesion classification using Customized Transfer Learning with Triple Attention.PloS one · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer is one of the leading significant causes of illness and chronic disease worldwide. Skin cancer, particularly melanoma, is becoming a severe health problem due to its rising prevalence. The considerable death rate linked with melanoma requires early detection to receive immediate and successful treatment. Lesion detection and classification are more challenging due to many forms of artifacts such as hairs, noise, and irregularity of lesion shape, color, irrelevant features, and textures. In this work, we proposed a deep-learning architecture for classifying multiclass skin cancer and melanoma detection. The proposed architecture consists of four core steps: image preprocessing, feature extraction and fusion, feature selection, and classification. A novel contrast enhancement technique is proposed based on the image luminance information. After that, two pre-trained deep models, DarkNet-53 and DensNet-201, are modified in terms of a residual block at the end and trained through transfer learning. In the learning process, the Genetic algorithm is applied to select hyperparameters. The resultant features are fused using a two-step approach named serial-harmonic mean. This step increases the accuracy of the correct classification, but some irrelevant information is also observed. Therefore, an algorithm is developed to select the best features called marine predator optimization (MPA) controlled Reyni Entropy. The selected features are finally classified using machine learning classifiers for the final classification. Two datasets, ISIC2018 and ISIC2019, have been selected for the experimental process. On these datasets, the obtained maximum accuracy of 85.4% and 98.80%, respectively. To prove the effectiveness of the proposed methods, a detailed comparison is conducted with several recent techniques and shows the proposed framework outperforms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.